XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income $ 139,909 $ 95,439
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 7,767 6,766
Amortization of debt issuance costs 247 91
Stock-based compensation 2,976 3,051
(Gain) loss on disposal of fixed assets 562 (2)
Deferred income taxes 2,286 3,061
Provision for legal settlement 0 (32,000)
Payment of legal settlement 0 (32,000)
Effect of changes in operating assets and liabilities:    
Receivables (35,324) (12,282)
Inventories (6,850) 8,257
Prepaid expenses and other assets (1,849) (2,066)
Accounts payable 20,812 4,055
Other liabilities (9,292) 5,158
Net cash provided by operating activities 121,244 111,528
Cash flows from investing activities:    
Capital expenditures (71,665) (17,901)
Restricted Cash 0 308
Proceeds from Sale of Productive Assets 0 15
Net cash used in investing activities (71,665) (18,194)
Cash flows from financing activities:    
Proceeds from borrowings of new debt 400,000 0
Repayment of long-term debt (382,147) 0
Payments related to long-term refinancing (4,382) 0
Principal payments on long-term debt (1,990) (2,970)
Repurchases of Common Stock 50,000 0
Net cash used in financing activities 4,527 1,805
Net cash provided by (used in) financing activities (33,992) (1,165)
Effect of exchange rate changes on cash and cash equivalents 139 (60)
Net increase in cash and cash equivalents 15,726 92,109
Cash and cash equivalents at beginning of period 292,656 224,253
Cash and cash equivalents at end of period 308,382 316,362
Supplemental schedule of non-cash investing activities    
Accruals related to property, plant and equipment $ 17,125 $ 0